| |
| |
|
| Insider
Information: |
Clayton Russell |
| Relationship: |
Chief Medical Officer |
| City: |
Warrington |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
30,966 |
|
|
Indirect Shares
|
18,854 |
|
|
| Direct
Value |
$27,263 |
|
|
|
Indirect Value
|
$3,092 |
|
|
| Total
Shares |
49,820 |
|
|
| Total
Value |
$30,355 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Windtree Therapeutics Inc |
WINT |
Senior VP, R&D |
2013-12-31 |
8,466 |
2013-12-31 |
18,854 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Chief Medical Officer |
2024-01-17 |
22,500 |
2024-01-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LRMR |
Larimar Therapeutics Inc |
Chief Medical Officer |
• – – |
2024-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
22,500 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2013-12-31 |
5 |
A |
$2.23 |
$4,375 |
I/I |
1,962 |
18,854 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2013-09-30 |
5 |
A |
$1.73 |
$4,373 |
I/I |
2,528 |
18,854 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2013-06-30 |
5 |
A |
$1.52 |
$4,376 |
I/I |
2,879 |
18,854 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2013-03-31 |
5 |
A |
$2.29 |
$4,374 |
I/I |
1,910 |
18,854 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2012-12-31 |
5 |
A |
$2.11 |
$4,252 |
I/I |
2,015 |
9,575 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2012-09-30 |
5 |
A |
$2.84 |
$4,249 |
I/I |
1,496 |
9,575 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2012-06-30 |
5 |
A |
$2.32 |
$4,250 |
I/I |
1,832 |
9,575 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2012-03-31 |
4 |
A |
$2.68 |
$4,250 |
I/I |
1,586 |
4,232 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&D |
• – – |
2011-12-31 |
5 |
A |
$1.68 |
$3,384 |
I/I |
2,014 |
2,646 |
0 |
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&DOfficer |
• – – |
2011-09-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
632 |
|
- |
|
| WINT |
Windtree Therapeutics Inc |
Senior VP, R&DOfficer |
• – – |
2011-09-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,466 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
